Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ACR | Ann: Launch of Dapsone 5%, Gel in the United States | 25/05/24 | 44 | 13K | |||
|
|||||||
ACR | Ann: Quarterly Activities/Appendix 4C Cash Flow Report | 22/05/24 | 10 | 3.0K | |||
|
|||||||
ACR | Ann: Quarterly Activities and Appendix 4C, reissued | 30/04/24 | 1 | 400 | |||
|
|||||||
ACR | Efinaconazole Topical Solution | 02/04/24 | 2 | 775 | |||
|
|||||||
ACR | onward and upward | 15:35 | 24 | 6.6K | |||
|
|||||||
ACR | Ann: Appendix 3Y Dobinson | 05/03/24 | 1 | 611 | |||
|
|||||||
ACR | Ann: Appendix 3Y Brumley | 05/03/24 | 0 | 201 | |||
|
|||||||
ACR | Ann: Application for quotation of securities - ACR | 05/03/24 | 0 | 215 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |